US 11,672,965 B2
Microneedle enclosure and applicator device for microneedle array based continuous analyte monitoring device
George Albert Mansfield, III, San Diego, CA (US); David Michael Morelock, Escondido, CA (US); Mark Christopher Brister, San Diego, CA (US); Nathan Thomas Balcom, San Marcos, CA (US); Joshua David Doan, Oceanside, CA (US); and Joshua Andrew Warner, Escondido, CA (US)
Assigned to Biolinq Incorporated, San Diego, CA (US)
Filed by Biolinq Incorporated, San Diego, CA (US)
Filed on Sep. 27, 2022, as Appl. No. 17/954,289.
Claims priority of provisional application 63/355,987, filed on Jun. 27, 2022.
Claims priority of provisional application 63/291,293, filed on Dec. 17, 2021.
Claims priority of provisional application 63/249,399, filed on Sep. 28, 2021.
Prior Publication US 2023/0099617 A1, Mar. 30, 2023
Int. Cl. A61M 37/00 (2006.01); A61B 5/145 (2006.01)
CPC A61M 37/0015 (2013.01) [A61B 5/14532 (2013.01); A61M 2037/0061 (2013.01)] 29 Claims
OG exemplary drawing
 
1. An applicator for an analyte monitoring device, the applicator comprising:
a housing comprising a body defining a cavity therein, wherein the housing body comprises a distal opening;
a cuff received within the cavity and comprising a lumen therethrough; and
a shuttle slidably received within the lumen and configured to releasably retain the analyte monitoring device,
wherein the applicator is movable between a collapsed configuration, an extended configuration, and a released configuration, and wherein
in the collapsed configuration, the analyte monitoring device is retained within the shuttle, and the shuttle and a distal edge of the cuff are in a proximal most position,
in the extended configuration, the distal edge of the cuff is in a distal most position and the shuttle is in an intermediate position, and
in the released configuration, the analyte monitoring device is released from the shuttle, the distal edge of the cuff is in an intermediate position, and the shuttle is in a distal most position.